Hooper Holmes' Heritage Labs Division to Manufacture Biospecimen Kits for the National Childr...( Heritage Labs Awarded Multi-Year ...),Health

Heritage Labs Awarded Multi-Year Contract from Westat

BASKING RIDGE, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Hooper Holmes (Amex: HH) today announced that its Heritage Labs division was awarded a contract to manufacture biospecimen kits for the National Children's Study (NCS) by Westat, an employee-owned corporation providing research services to agencies of the U.S. Government as well as businesses, foundations, and state and local governments. This component of the NCS was awarded to Westat by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under contract number HHSN275200503395C.

Mandated by Congress in the Children's Health Act of 2000, the NCS is a collaborative effort involving many public and private partners committed to improving children's health. The Study is led by a consortium of federal agencies including: the U.S. Department of Health and Human Services (the NICHD and the National Institute of Environmental Health Sciences within the NIH, and the Centers for Disease Control and Prevention) and the U.S. Environmental Protection Agency.

The NCS is a major longitudinal cohort study that will follow children from before birth to at least 21 years of age and will evaluate the effects of a variety of environmental factors, including chemical, physical, biological, and psychosocial factors, on children's health and well-being. Researchers will analyze how these elements interact with each other and what helpful and/or harmful effects they might have on children's health. Data will be collected from children and their families from different areas of the country, from varied backgrounds, and of different family types.

"We are proud to have been selected as the so
'/>"/>